Neuberg, which runs a pan-India diagnostic chain, has appointed O3 Capital as the investment banker and is currently in talks with potentia...

As a result of the acquisition, the group gross revenue of Neuberg Diagnostics is expected to be over Rs 1,000 crore during the current fin...

PharmEasy was supposed to raise equity of around Rs 1,000 crore, or about $120 million, linked to its burn rate velocity. It has failed to ...

Besides chairman GSK Velu, the other founding members of Neuberg Diagnostics are Anand Diagnostic Laboratory (Bengaluru), Supratech Micropa...

The IPO of PharmEasy’s parent API Holdings is expected to be a fully primary share sale. The e-pharmacy — India’s largest — aims to list be...

PharmEasy founders — Siddharth Shah, Dhaval Shah, Dhramil Sheth, Harsh Parekh and Hardik Dedhia — have received new stock options ahead of ...

From refrigerators to clothes, ecommerce firms accounted for a higher share of total sales than they did this time last year. Read on to fi...

GSK Velu, founder of both companies, is looking at aggressively acquiring pathology chains and medical equipment makers in these markets th...

Its Rs 1,204-crore initial public offer (IPO) opened for subscription on Wednesday.

The price band has been fixed in the range of Rs 877-880 per share.